Dr. Mohammed Milhem, MB BS

• Hematology

• Hematology & Oncology

• Internal Medicine

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Jordan University Of Science And Technology

  Medical School, 1995

• Epigenetic silencing of the humanNOS2gene: Rethinking the role of nitric oxide in human macrophage inflammatory responses, 2014-01-29

• Overcoming PD-1 Blockade Resistance With CpG-A Toll-Like Receptor 9 Agonist Vidutolimod in Patients With Metastatic Melanoma, 2021-12-01

• Signaling pathways in adenoid cystic cancers Implications for treatment, 2009-10-22

• The Impact of TSC-1 and -2 Mutations on Response to Therapy in Malignant PEComa: A Multicenter Retrospective Analysis, 2022-10-24

• Efficacy of Nelfinavir as Monotherapy in Refractory Adenoid Cystic Carcinoma: Results of a Phase II Clinical Trial, 2014-06-18

• Melanoma Brain Metastases in the Era of Targeted Therapy and Checkpoint Inhibitor Therapy, 2021-03-24

• Correlation of MTDH/AEG-1 and HOTAIR Expression with Metastasis and Response to Treatment in Sarcoma Patients, 2011-12-29

• Neoadjuvant Radiotherapy-Related Wound Morbidity in Soft Tissue Sarcoma: Perspectives for Radioprotective Agents, 2020-08-12

• Effect of Selumetinib versus Chemotherapy on Progression-Free Survival in Uveal Melanoma: A Randomized Clinical Trial, 2014-06-18

• 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts National Harbor, MD, USA. 9-13 November 2016, 2016-12-08

• Impact of Sequencing Targeted Therapies With High-dose Interleukin-2 Immunotherapy: An Analysis of Outcome and Survival of Patients With Metastatic Renal Cell Carcinoma From an On-going Observational IL-2 Clinical Trial: PROCLAIMSM, 2016-10-29

• Patterns of response with talimogene laherparepvec in combination with ipilimumab or ipilimumab alone in metastatic unresectable melanoma, 2019-07-29

• Obesity Does Not Exacerbate the Protumorigenic Systemic Environment in Sarcoma Subjects, 2017-06-05

• Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy, 2018-02-27

• A phase II clinical study of 13-deoxy, 5-iminodoxorubicin (GPX-150) with metastatic and unresectable soft tissue sarcoma, 2019-04-23

• Quantitative computed tomography determined regional lung mechanics in normal nonsmokers, normal smokers and metastatic sarcoma subjects, 2017-07-27

• TAZ and YAP are frequently activated oncoproteins in sarcomas, 2016-04-25

• SARC006: Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated Chemotherapy-Naive Malignant Peripheral Nerve Sheath Tumors, 2017-09-12

• The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to Sarcoma, 2023-03-29